These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 851961)

  • 1. Intracellular localization of tumor-associated antigens in murine and human malignant melanoma.
    Kerney SE; Montague PM; Chretien PB; Nicholson JM; Ekel TM; Hearing VJ
    Cancer Res; 1977 May; 37(5):1519-24. PubMed ID: 851961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of tumor-associated antigens shed by human melanoma cells in culture.
    Boctor AM; Bystryn JC
    Cancer Res; 1982 Jun; 42(6):2121-5. PubMed ID: 7074593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on antigenicity and immunogenicity of transplantable melanoma in hamster by using migration inhibition test.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):445-7. PubMed ID: 749795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation of soluble tumor-associated antigens of human malignant melanoma].
    Suter L
    Fortschr Med; 1978 Aug; 96(32):1615-8. PubMed ID: 680624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of tumor-associated antigens by murine melanoma cells.
    Bystryn JC
    J Immunol; 1976 May; 116(5):1302-5. PubMed ID: 1270797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens.
    Fukaya T; Hashimoto K; Eto H; Mehregan A
    Cancer Res; 1986 Oct; 46(10):5195-200. PubMed ID: 3756874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of murine tumor-associated antigens by the micro-leukocyte adherence inhibition assay.
    Howell JH; Russo AJ; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):612-8. PubMed ID: 83914
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane associated antigens of human malignant melanoma. II. Leucocyte migration studies with formalin fixed human melanoma cells.
    Suter L; Sorg C; Macher E
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):242-9. PubMed ID: 134542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
    Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
    Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cell clones specific for the human p97 melanoma-associated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen.
    Kahn M; Sugawara H; McGowan P; Okuno K; Nagoya S; Hellström KE; Hellström I; Greenberg P
    J Immunol; 1991 May; 146(9):3235-41. PubMed ID: 1707934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological and immunochemical analysis of the specificity of xenoantiserum 8986 elicited with hybrids between human melanoma cells and murine fibroblasts.
    Imai K; Galloway DR; Ferrone S
    Cancer Res; 1981 Mar; 41(3):1028-33. PubMed ID: 6161692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
    Nifontova TP
    Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harding-Passey melanoma in the BALB-C mouse as a model for studying the interactions between host macrophages and tumor cells.
    Lejeune FJ
    Yale J Biol Med; 1973 Dec; 46(5):368-83. PubMed ID: 4205114
    [No Abstract]   [Full Text] [Related]  

  • 19. Serologically detectable MHC and tumor-associated antigens on B16 melanoma variants and humoral immunity in mice bearing these tumors.
    Baniyash M; Smorodinsky NI; Yaakubovicz M; Witz IP
    J Immunol; 1982 Sep; 129(3):1318-23. PubMed ID: 7108209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.